Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;4(5):270-6.
doi: 10.1007/s12672-013-0149-7. Epub 2013 May 29.

Antiestrogen use and survival of women with non-small cell lung cancer in Manitoba, Canada

S A Lother  1 , G A Harding, G Musto, S Navaratnam, M W Pitz
Affiliations

Antiestrogen use and survival of women with non-small cell lung cancer in Manitoba, Canada

S A Lother et al. Horm Cancer. 2013 Oct.

Abstract

Lung cancer is the leading cause of cancer death worldwide. Sex differences in lung cancer incidence and survival are known. Female sex is an independent good prognostic factor. Estrogens appear to play a key role in lung cancer outcomes. Accordingly, antiestrogen use may also influence survival in female non-small cell lung cancer (NSCLC) patients. In this study, we compared survival among antiestrogen users and nonusers. We performed a retrospective population-based study. Using the Manitoba Cancer Registry (MCR), we identified all women diagnosed with NSCLC from 2000 to 2007. The population-based Drug Program Information Network was accessed to establish which patients received antiestrogens. Demographic data (e.g., smoking patterns, stage, histology) were gathered from the MCR and by chart review. Survival differences between antiestrogen-exposed and not exposed groups were compared using multivariable Cox regression. Two thousand three hundred twenty women fit our patient criteria, of which 156 had received antiestrogens. Exposure to antiestrogens was associated with a significantly decreased mortality in those exposed both before and after the diagnosis of NSCLC (adjusted hazard ratio, 0.42, p = 0.0006). This association remained consistent across age and stage groups. Antiestrogen use before and after the diagnosis of NSCLC is associated with decreased mortality. This supports previous evidence that estrogens may play a key role in the biology and outcomes of NSCLC and suggests a potential therapeutic use for these agents in this disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Unadjusted Kaplan–Meier survival function by antiestrogen exposure vs. no exposure
See this image and copyright information in PMC

References

    1. Ayeni O, Robinson A. Hormone replacement therapy and outcomes for women with non-small cell lung cancer: can an association be confirmed. Current Oncol. 2009;16:21–25. doi: 10.3916/c32-2009-02-001. - DOI - PMC - PubMed
    1. Bogush TA, Dudko EA, Beme AA, Bogush EA, Kim AI, Polotsky BE, Tjuljandin SA, Davydov MI. Estrogen receptors, antiestrogens, and non-small cell lung cancer. Biochemistry (Mosc) 2010;75(12):1421–1427. doi: 10.1134/S0006297910120011. - DOI - PubMed
    1. Bouchardy C, Benhamou S, Schaffar R, Verkooijen HM, Fioretta G, Schubert H, Vinh-Hung V, Soria J-C, Vlastos G, Rapiti E. Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. Cancer. 2011;117(6):1288–1295. doi: 10.1002/cncr.25638. - DOI - PubMed
    1. Canadian Cancer Statistics 2012 (2012) Canadian Cancer Society. http://www.cancer.ca. Accessed December 2012
    1. Registries Certified in 2007 for 2004 Incidence Data. North American Association of Central Cancer Registries (NAACCR). http://www.naaccr.org. Accessed May 2013.

Publication types

Substances